Skip to content

Clinical study on artificial Intelligence aided diagnosis of lymphatic metastasis of gastric cancer based on digital pathology

Clinical study on artificial Intelligence aided diagnosis of lymphatic metastasis of gastric cancer based on digital pathology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046812
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:Artificial&#32
Intelligence&#32
diagnosis&#32
of&#32
cancer&#32
based&#32
on&#32
pathology

Sponsors

The Seventh affiliated Hospital of Sun Yat-en University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Non-bedridden patients, aged from 18 to 75 years, male or female; 2. Gastric adenocarcinoma confirmed by histopathology and/or cytology (including adenocarcinoma of gastroesophageal junction); 3. The subjects voluntarily joined the study, signed the informed consent form, had good compliance and cooperated with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Have suffered from other malignant tumors in the past 5 years, except for cured basal cell carcinoma of the skin and carcinoma in situ of the cervix; 2. Those who had received chemotherapy, radiotherapy or immunotherapy before participating in this study; 3) Any uncontrolled systemic diseases, including active infection, uncontrolled hypertension, diabetes, unstable angina pectoris, congestive heart failure, myocardial infarction (within 1 year before the start of treatment), severe arrhythmias requiring drug treatment, liver, kidney and metabolic diseases; 4. Accompanied by dysphagia, complete or incomplete digestive tract obstruction, active gastrointestinal bleeding, perforation; 5. Pregnant or lactating women; 6. Subjects who did not accept contraceptive requests during the study period; 7. Patients with a history of psychotropic substance abuse and unable to quit or with mental disorders; 8. Patients who are known to be allergic to possible chemotherapeutic drugs; 9. The researchers think that it is not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Accuracy rate;

Countries

China

Contacts

Public ContactXue Ling

The Seventh Affiliated Hospital of Sun Yat-Sen University

xuel@mail.sysu.edu.cn+86 18922811582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026